CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 72 enrolled
Drug / intervention
t:slim X2 insulin pump with Control-IQ technology 2.0device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05683392
NCT05683392N/ACompleted
CompareCT.gov

Control-IQ 2.0 Feasibility Study #2: Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes

Tandem Diabetes Care, Inc.·interventional·Posted Jan 13, 2023·Updated Dec 20, 2024

In Brief

A clinical study evaluating t:slim X2 insulin pump with Control-IQ technology 2.0 for Type 1 Diabetes. Completed, enrolled 72 participants across 4 sites.

Detailed Summary

The goal of this clinical trial is to assess safety of and explore glycemic outcomes with Control-IQ technology 2.0 in adults, children and preschoolers with type 1 diabetes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJan 13, 2023
Enrollment StartFeb 1, 2023
Primary CompletionDec 13, 2023
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 3.5 years ago

Interventions

t:slim X2 insulin pump with Control-IQ technology 2.0device

t:slim X2 insulin pump with Control-IQ technology 2.0, and wearing the Dexcom G6 sensor.